Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

Volume: 2020, Pages: 1835836 - 1835836
Published: Jun 6, 2020
Abstract
The aim of the study was to determine the levels of selected cytokines and chemokines in the serum of multiple myeloma (MM) patients treated with bortezomib-based regimens. A total of 71 MM patients were examined: 41 with primary refractory disease (17) or early relapse (28), and 30 who were bortezomib sensitive with no progression for at least six months. Patients who demonstrated CR or PR after bortezomib-based therapies longer than six months...
Paper Details
Title
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib
Published Date
Jun 6, 2020
Volume
2020
Pages
1835836 - 1835836
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.